2. WWW.RESEARCHVIA.COM +91- 99777-85000
Nifty ends 100 pts up; RIL, Sun Pharma up 5%
Economists forecast India Q4 GDP at 4.8%
TTK Healthcare Q4 net declines 39.6% to Rs 2.24cr
3G case: HC issues contempt notices to Idea Cellular, others
JSW Steel's Q4 net down 24% on higher interest cost
Reliance Communications up 4% on pre-paid call rates hike
ECONOMY ANALYSIS
The BSE benchmark Sensex today surged the most in two weeks by
jumping 326 points to close at 20,030.77 points on all-round buying led by
a rally in RILBSE 5.12 % and Sun PharmaBSE 4.66 % on positive reports
amid a firming global trend.
The Sensex shot up by 326.44 points, or 1.66 per cent, to 20,030.77, led
by consumer durables, and oil and gas sectors driven by a steep rise in
Reliance Industries.
The broad-based National Stock Exchange index Nifty shot up by 99.60
points, or 1.66 per cent, to 6,083.15. MCX-SX flagship index SX40 also
closed higher by 214.5 points, or 1.84 per cent, at 11,681.13.
Sun Pharma spurted by 4.66 per cent to Rs 1,014.85 ahead of the quarter
earnings, while Bharti Airtel BSE 3.31 % rose by 3.31 per cent to Rs
209.15
The major gainers were Infosys, Coal India, BHEL BSE 2.02 %, Dr
Reddy's Lab, HDFC Bank, Hindalco, Hero MotoCorpBSE 1.62 %, Jindal
Steel, Tata MotorsBSE 2.20 %, Tata SteelBSE 1.23 %, TCS and Wipro.
MARKET ANALYSIS
3. WWW.RESEARCHVIA.COM +91- 99777-85000
INDEX CLOSE CHANGE % CHANGE
SENSEX 20030.77 326.44 1.66
NIFTY 6083.15 99.60 1.66
BANK NIFTY 12961.55 192.20 1.51
INDEX CLOSE CHANGE
FTSE 6654.34 -42.45
CAC 3982.87 26.08
DAX 8349.75 44.43
INDEX CLOSE CHANGE
NIKKEI 14142.65 -469.80
STRAITS
TIMES
3391.30 -1.87
HANG SENG 22686.05 67.38
TAIWAN
INDEX
8280.10 70.32
KOSPI 1979.97 6.52
INDEX CLOSE CHANGE
DOW
FUTURES
15309.00 2.00
NASDAQ
FUTURES
2994.00 1.75
MAJOR INDICES
INDIAN MARKETS
EUROPEAN MARKETASIAN MARKETS
US MARKETS
4. WWW.RESEARCHVIA.COM +91- 99777-85000
SCRIPS RATE VOL. (000) PR. CLOSE NET
CHANGE
% CHANGE
Indusind 529.35 2357.82 498.25 31.1 6.24
RIL 828.3 4332.76 786.45 41.85 5.32
Sun Pharma 1013.7 1674.8 968.85 44.85 4.63
Jindal Steel 306.6 2559.86 295.05 11.55 3.91
Ranbaxy 404.8 1400.44 389.7 15.1 3.87
SCRIPS RATE VOL. (000) PR. CLOSE NET
CHANGE
% CHANGE
Cipla 401.5 838.32 408.5 -7 -1.71
M & M 951.9 622.16 968.1 -16.2 -1.67
Maruti 1648.75 584.14 1674.9 -26.15 -1.56
Lupin 759.15 1352.95 769.65 -10.5 -1.36
BOB 682.25 1527.84 691.5 -9.25 -1.34
DAILY GAINERS AND LOOSERS
GAINERS
LOOSERS
5. WWW.RESEARCHVIA.COM +91- 99777-85000
CATEGORY DATE BUY VALUE SELL VALUE
NET
VALUE
FII 27-May-2013 2525.75 2119.72 406.03
DII 27-May-2013 696.51 1212.9 -516.39
INDEX S1 S2 PP R1 R2
NIFTY 5993 5918 6046 6121 6174
BANK NIFTY 12723 12558 12843 13008 13128
FII AND DII TRADING DATA
DAILY PIVOTS
Aban Offshore 28-May-2013
Bombay Dyeing 28-May-2013
Colgate 28-May-2013
GAIL 28-May-2013
Godrej Ind 28-May-2013
Gravita India 28-May-2013
Havells India 28-May-2013
Hindalco 28-May-2013
HPCL 28-May-2013
PVR 28-May-2013
Tata Comm 28-May-2013
Tata Global Bev 28-May-2013
Upcoming quarterly results
HDIL
RENUKA
Scrips in Ban period
6. WWW.RESEARCHVIA.COM +91- 99777-85000
All data and reports at Research Via are only information services for subscribers and are not
individualized recommendations to buy or sell securities, nor offers to buy or sell securities. Under any
circumstances the subscription amount paid to Research Via are not refundable. Investment in equity
shares, futures, options and commodities has its own risks. Sincere efforts have been made to present
the right investment perspective. The information contained herein is based on analysis and on sources
that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This
material is for personal information and we are not responsible for any loss incurred due to it & take no
responsibility whatsoever for any financial profits or loss which may arise from the recommendations
above.
This Website is for information purposes only. The information contained on this should not be
construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for the units of the
schemes of Research Via. Research Via is neither responsible nor liable for third party content provided
or content from any other aspect of any other Website, which may be accessed from this Website. A
possibility exists that the site could include inaccuracies or errors. Additionally, a possibility exist that
unauthorized additions, deletions or alterations could be made by third parties to the site. Although
Research Via attempts to ensure the integrity, correctness and authenticity of the site, it makes no
guarantees whatsoever as to its completeness, correctness or accuracy. In the event, that such an
inaccuracy arises, please inform Research Via so that it can be corrected.
Research Via and its owners/affiliates are not liable for damages caused by any performance, failure of
performance, error, omission, interruption, deletion, defect, delay in transmission or operations,
computer virus, communications line failure, and unauthorized access to the personal accounts.
Research Via is not responsible for any technical failure or malfunction of the software or delays of any
kind. We are also not responsible for non-receipt of registration details or e-mails. Research Via is not
responsible for the content of any of the linked sites. By providing access to other web-sites, Research
Via is neither recommending nor endorsing the content available in the linked websites.
All data and reports at Research Via are only information services for subscribers and are not
individualized recommendations to buy or sell securities, nor offers to buy or sell securities.
Under any circumstances the subscription amount paid to Research Via are not refundable.
Investment in equity shares, futures, options and commodities has its own risks. Sincere efforts
have been made to present the right investment perspective. The information contained herein
is based on analysis and on sources that we consider reliable. We, however, do not vouch for the
accuracy or the completeness thereof. This material is for personal information and we are not
responsible for any loss incurred due to it & take no responsibility whatsoever for any financial
profits or loss which may arise from the recommendations above.
This Website is for information purposes only. The information contained on this should not be
construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for the units
of the schemes of Research Via. Research Via is neither responsible nor liable for third party
content provided or content from any other aspect of any other Website, which may be accessed
from this Website. A possibility exists that the site could include inaccuracies or errors.
Additionally, a possibility exist that unauthorized additions, deletions or alterations could be
made by third parties to the site. Although Research Via attempts to ensure the integrity,
correctness and authenticity of the site, it makes no guarantees whatsoever as to its
completeness, correctness or accuracy. In the event, that such an inaccuracy arises, please
inform Research Via so that it can be corrected.
Research Via and its owners/affiliates are not liable for damages caused by any performance,
failure of performance, error, omission, interruption, deletion, defect, delay in transmission or
operations, computer virus, communications line failure, and unauthorized access to the
personal accounts. Research Via is not responsible for any technical failure or malfunction of
the software or delays of any kind. We are also not responsible for non-receipt of registration
details or e-mails. Research Via is not responsible for the content of any of the linked sites. By
providing access to other web-sites, Research Via is neither recommending nor endorsing the
content available in the linked websites.
DISCLAIMER
